These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4070991)

  • 1. The effect of dialyser membrane material on intradialytic changes in platelet count, platelet aggregation, circulating platelet aggregates and antithrombin III.
    Knudsen F; Nielsen AH; Kristensen SD
    Scand J Urol Nephrol; 1985; 19(3):227-32. PubMed ID: 4070991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets and antithrombin III in uraemia: the acute effect of haemodialysis.
    Knudsen F; Dyerberg J
    Scand J Clin Lab Invest; 1985 Jun; 45(4):341-7. PubMed ID: 3160101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of coagulation and platelet functions in heparin-free hemodialysis.
    Ivanovich P; Xu CG; Kwaan HC; Hathiwala S
    Nephron; 1983; 33(2):116-20. PubMed ID: 6835458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dialyzer geometry during hemodialysis with cuprophane membranes.
    Taylor JE; McLaren M; Mactier RA; Henderson IS; Stewart WK; Belch JJ
    Kidney Int; 1992 Aug; 42(2):442-7. PubMed ID: 1405328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry.
    Docci D; Turci F; Del Vecchio C; Bilancioni R; Cenciotti L; Pretolani E
    Int J Artif Organs; 1984 Nov; 7(6):337-40. PubMed ID: 6526528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyacrilonytrile versus cuprophan membranes for hemodialysis: evaluation of efficacy and biocompatibility by platelet aggregation studies.
    Berrettini M; Buoncristiani U; Parise P; Ballatori E; Nenci GG
    Int J Artif Organs; 1981 Sep; 4(5):218-22. PubMed ID: 7319659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation.
    De Sanctis LB; Stefoni S; Cianciolo G; Colì L; Buscaroli A; Feliciangeli G; Borgnino LC; Bonetti M; Gregorini MC; De Giovanni P; Buttazzi R
    Int J Artif Organs; 1996 Jul; 19(7):404-10. PubMed ID: 8841854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility and clinical performance of a new modified cellulose membrane.
    Bosch T; Schmidt B; Samtleben W; Gurland HJ
    Clin Nephrol; 1986; 26 Suppl 1():S22-9. PubMed ID: 3829464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two hemodialysis membranes, polyacrylonitrile and cellulose acetate, on complement and coagulation systems.
    Moll S; De Moerloose P; Reber G; Schifferli J; Leski M
    Int J Artif Organs; 1990 May; 13(5):273-9. PubMed ID: 2142140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in leukocyte counts using a cellulose acetate membrane (FB-T) during hemodialysis. A comparison with a cuprophane membrane].
    Pak K; Kobira S; Tomoyoshi T; Nishimura N
    Hinyokika Kiyo; 1986 Sep; 32(9):1231-5. PubMed ID: 3812143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases in circulating level of platelet-activating factor lag behind transient neutropenia during hemodialysis with cuprophane membranes.
    Sakaguchi K; Morimoto S; Chen YH; Nakamoto Y; Ogihara T
    Nephron; 1991; 59(3):455-60. PubMed ID: 1758537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hemodialysis and peritoneal dialysis on antithrombin III and platelets.
    Woo KT; Wei SS; Lee EJ; Lau YK; Lim CH
    Nephron; 1985; 40(1):25-8. PubMed ID: 4000334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of cellulose triacetate and polysulfone membrane on GPIIb/IIIa and platelet activation.
    Kuragano T; Kuno T; Takahashi Y; Yamamoto C; Nagura Y; Takahashi S; Kanmatsuse K
    Blood Purif; 2003; 21(2):176-82. PubMed ID: 12601261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia.
    Daugirdas JT; Bernardo AA
    Kidney Int; 2012 Jul; 82(2):147-57. PubMed ID: 22592187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis.
    Sirolli V; Strizzi L; Di Stante S; Robuffo I; Procopio A; Bonomini M
    Thromb Haemost; 2001 Sep; 86(3):834-9. PubMed ID: 11583316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reticulated platelets in uremic patients: effect of hemodialysis and continuous ambulatory peritoneal dialysis.
    Tàssies D; Reverter JC; Cases A; Escolar G; Villamor N; López-Pedret J; Castillo R; Ordinas A
    Am J Hematol; 1995 Nov; 50(3):161-6. PubMed ID: 7485076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis.
    Akizawa T; Kinugasa E; Koshikawa S
    ASAIO Trans; 1991; 37(3):M384-5. PubMed ID: 1751199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-leukocyte aggregation during hemodialysis.
    Gawaz MP; Mujais SK; Schmidt B; Gurland HJ
    Kidney Int; 1994 Aug; 46(2):489-95. PubMed ID: 7526025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysis membranes and coagulation system.
    Notohamiprodjo M; Andrassy K; Bommer J; Ritz E
    Blood Purif; 1986; 4(1-3):130-41. PubMed ID: 2942155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble P-selectin is released from activated platelets in vivo during hemodialysis.
    Kawabata K; Nagake Y; Shikata K; Fukuda S; Nakazono H; Takahashi M; Ichikawa H; Makino H
    Nephron; 1998; 78(2):148-55. PubMed ID: 9496730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.